Arbutus Biopharma Corp
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $195.4M
Liabilities Breakdown FY2022
Total Liabilities: $58.6M
Asset Breakdown
Total Assets: $195.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $30.8M | 15.7% |
| Accounts Receivable | $1.4M | 0.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.1M | 2.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $158.2M | 81.0% |
Liabilities Breakdown
Total Liabilities: $58.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.5M | 6.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $55.0M | 94.0% |